5.1 Challenges encountered in preclinical trials Several drugs have been shown to inhibit ferroptosis in animal experiments, but they mostly suffer from low stability, low solubility, low targeting, low safety, toxicity, poor pharmacokinetics, and low activity (Guo et al., 2023), so very few of them have entered clinical studies
In addition, Semaglutide GLP-1 slows down gastric emptying, which prolongs the feeling of fullness and reduces the urge to snack between meals
Summary: This phase 3a, 68-week, double-blind, placebo-controlled trial investigated the efficacy and safety of coadministering Cagrilintide and Semaglutide
so good
Data from clinical studies In an observational study involving 20 diabetic subjects receiving background metformin therapy, exenatide treatment over 16 weeks resulted in improved flow-mediated vasodilation of the brachial artery following 5 min of forearm ischemia, as assessed by ultrasound echocardiography, compared to patients treated with glimepiride [85]